期刊文献+

Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants 被引量:4

Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants
原文传递
导出
摘要 The human pathogen, group A rotavirus, is the most prevalent cause of acute infantile and pediatric gastroenteritis worldwide, especially in developing countries. There is an urgent demand for safer, more effective and cheaper vaccines against rotavirus infection. Plant-derived antigens may provide an exclusive way to produce economical subunit vaccines. Virus-like particles, constituting viral capsid proteins without viral nucleic acids, are considered a far safer candidate compared with live attenuated viral vaccines. In this study, the rotavirus capsid proteins VP2, VP6 and VP7 were co-expressed in transgenic tobacco plants, and their expression levels, formation of rotavirus-like particles (RV VLPs) and immunogenicity were extensively studied. Quantitative real-time RT-PCR and Western blot analysis revealed that the expression level of vp6 was the highest while vp7 was expressed at the lowest levels. The RV VLPs were purified from transgenic tobacco plants and analyzed by electron microscopy and Western blot. Results indicated that the plant-derived VP2, VP6 and VP7 proteins self-assembled into 2/6 or 2/6/7 RV VLPs with a diameter of 60-80 nm. When orally delivered into mice with cholera toxin as an adjuvant, the total soluble protein extracted from transgenic tobacco plants induced rotavirus-specific antibodies comparable with those of attenuated rotavirus vaccines, while VP 2/6/7 induced higher serum IgG and fecal IgA titers compared with VP 2/6. The human pathogen, group A rotavirus, is the most prevalent cause of acute infantile and pediatric gastroenteritis worldwide, especially in developing countries. There is an urgent demand for safer, more effective and cheaper vaccines against rotavirus infection. Plant-derived antigens may provide an exclusive way to produce economical subunit vaccines. Virus-like particles, constituting viral capsid proteins without viral nucleic acids, are considered a far safer candidate compared with live attenuated viral vaccines. In this study, the rotavirus capsid proteins VP2, VP6 and VP7 were co-expressed in transgenic tobacco plants, and their expression levels, formation of rotavirus-like particles (RV VLPs) and immunogenicity were extensively studied. Quantitative real-time RT-PCR and Western blot analysis revealed that the expression level of vp6 was the highest while vp7 was expressed at the lowest levels. The RV VLPs were purified from transgenic tobacco plants and analyzed by electron microscopy and Western blot. Results indicated that the plant-derived VP2, VP6 and VP7 proteins self-assembled into 2/6 or 2/6/7 RV VLPs with a diameter of 60–80 nm. When orally delivered into mice with cholera toxin as an adjuvant, the total soluble protein extracted from transgenic tobacco plants induced rotavirus-specific antibodies comparable with those of attenuated rotavirus vaccines, while VP 2/6/7 induced higher serum IgG and fecal IgA titers compared with VP 2/6.
出处 《Science China(Life Sciences)》 SCIE CAS 2011年第1期82-89,共8页 中国科学(生命科学英文版)
基金 supported by the National High Technology Research and Development Program of China (Grant No. 2007AA100505)
关键词 转基因烟草植株 轮状病毒感染 病毒衣壳蛋白 植物生产 免疫原性 基因表达水平 病毒样颗粒 BLOT分析 rotavirus virus-like particles transgenic plant oral vaccine immunogenicity
  • 相关文献

参考文献43

  • 1Banos D M,Lopez S,Arias C F, et al.Identification of a T-helper cell epitope on the rotavirus VP6 protein. Journal of Virology . 1997
  • 2Andrew M E,Boyle D B,Coupar B E, et al.Vaccinia-rotavirus VP7 recombinants protect mice against rotavirus-induced diarrhoea. Vac- cine . 1992
  • 3Kapikian A Z,Hoshino Y,Chanock R M, et al.Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. The Journal of Infectious Diseases . 1996
  • 4Centers for Disease Control and Prevention.Withdrawal of rotavirus vaccine recommendation. The Journal of The American Medical Association . 1999
  • 5Richardson V,Hernandez-Pichardo J,Quintanar-Solares M, et al.Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. The New England Journal of Medicine . 2010
  • 6Vesikari T,Clark H F,Offit P A, et al.Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant ro- tavirus vaccine on efficacy, safety and immunogenicity in healthy in- fants. Vaccine . 2006
  • 7Choi A H,Basu M,Rae M N, et al.Particle-bombardment-mediated DNA vaccination with rotavirus VP4 or VP7 induces high levels of serum rotavirus IgG but fails to protect mice against challenge. Journal of Virology . 1998
  • 8Yuan L,Saif L J.Induction of mucosal immune responses and pro- tection against enteric viruses: Rotavirus infection of gnotobiotic pigs as a model. Veterinary Immunology and Immunopathology . 2002
  • 9Tacket C O.Plant-derived vaccines against diarrhoeal diseases. Ex- pert Opin Biol Ther . 2004
  • 10Kohl T,Hitzeroth I I,Stewart D, et al.Plant-produced cottontail rab- bit papillomavirus L1 protein protects against tumor challenge: A proof-of-concept study. Clin Vaccine Immunol . 2006

同被引文献107

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部